Spelling suggestions: "subject:"anticoagulants"" "subject:"anticoagulantes""
1 |
Les Hémorragies du traitement anticoagulant oral révélatrices de tumeur.Pratelli, Massimo, January 1900 (has links)
Th.--Méd.--Nancy 1, 1983. N°: 185.
|
2 |
DicumarolSteel, Robert MacDonald January 1945 (has links)
Thesis (M.D.)--Boston University
|
3 |
Dental extraction in patients receiving oral anticoagulant therapyTroulis, Maria J. January 1997 (has links)
Thesis (M.S.)--McGill University, 1997. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
|
4 |
Dental extraction in patients receiving oral anticoagulant therapyTroulis, Maria J. January 1997 (has links)
Thesis (M.S.)--McGill University, 1997. / Includes bibliographical references.
|
5 |
BODY BURDEN DETERMINATION AND METABOLITE IDENTIFICATION OF DIPHACINONE IN THE MOUSECahill, William Patrick, 1938- January 1977 (has links)
No description available.
|
6 |
Heparin and cranial neurulation in the ratKesby, Gregory John January 1992 (has links)
No description available.
|
7 |
Activated protein C is a logical adjunct to heparin during cardiovascular interventionO'Regan, David John January 2000 (has links)
No description available.
|
8 |
Contribution au développement d'actionneurs électroactifs pour l'assistance circulatoire application à la mise au point d'une fonction antithrombotique /Viguier, Christophe Nogarède, Bertrand. January 2006 (has links)
Reproduction de : Thèse de doctorat : Génie électrique : Toulouse, INPT : 2005. / Titre provenant de l'écran-titre. Bibliogr. 90 réf.
|
9 |
Extracorporeal blood circulation in the rat : Utilisation in the evaluation of antithrombotic agents and membrane biomaterialsMorrice, L. M. A. January 1987 (has links)
No description available.
|
10 |
A third international survey to study clinical laboratory testing for the lupus anticoagulantBarna, Linda Kathern January 1995 (has links)
Lupus anticoagulants (LA) are immunoglobulins (IgG, IgM, IgA or a mixture) that interfere with in vitro phospholipids (PL) dependent coagulation tests. Variable test results among LA positive individuals are due to the heterogeneous nature of the antibodies and differences in reagent/instrument systems. A laboratory’s ability to differentiate LA from other coagulation abnormalities and to accurately establish PL dependence is determined by the sensitivity and responsiveness of screening assays and specificity of confirmatory tests. The Third International Survey on Lupus Anticoagulants (ISLA-3) was organized to assess current protocols for LA testing and determine the sensitivity and specificity of confirmatory tests. A written survey and samples for evaluation were sent to 41 participants from five continents. A majority of laboratories performed 2 screening tests and all performed mixing studies if a screening test was abnormal. Confirmatory tests were done if mixing studies suggested the presence of an inhibitor. New confirmatory assays proved to be more specific than methods previously in place.Ball State UniversityMuncie, IN 47306 / Center for Medical Education
|
Page generated in 0.065 seconds